

![]() |
Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis |
|
Authors | ![]() | |
Collaboration | With : Belli, Dominique Charles / Zamora, Samuel Antonio | |
Published in | Journal of Crohn's and colitis. 2014, vol. 8, no. 8, p. 825-834 | |
Abstract | Anti-TNFα agents are commonly used for ulcerative colitis (UC) therapy in the event of non-response to conventional strategies or as colon-salvaging therapy. The objectives were to assess the appropriateness of biological therapies for UC patients and to study treatment discontinuation over time, according to appropriateness of treatment, as a measure of outcome. | |
Keywords | Adolescent — Adult — Aged — Colitis, Ulcerative/drug therapy — Female — Humans — Immunologic Factors/adverse effects/therapeutic use — Inappropriate Prescribing/statistics & numerical data — Longitudinal Studies — Male — Middle Aged — Treatment Outcome — Tumor Necrosis Factor-alpha/antagonists & inhibitors — Young Adult | |
Identifiers | PMID: 24462322 | |
Full text | ||
Structures | ||
Research group | Gastroentérologie et transplantation (pédiatrie) (181) | |
Citation (ISO format) | MAILLARD, Michel H et al. Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis. In: Journal of Crohn's and Colitis, 2014, vol. 8, n° 8, p. 825-834. doi: 10.1016/j.crohns.2013.12.026 https://archive-ouverte.unige.ch/unige:74910 |